The US intoxicating hemp market, thought to be worth around $28bn in annual sales, could yet be saved from a devastating ban set to be implemented in a matter of months.
Efforts to close the so-called ‘hemp loophole’ in the US, which would have banned the sale of hemp-derived products containing any detectable amount of THC, could be postponed by a year, giving operators room to adapt their operations.
The US Food and Drug Administration (FDA) was dragged through the mud by lawmakers yesterday, who said its ‘bureaucratic red tape, inefficiencies, and weak oversight’ was responsible for the flood of intoxicating hemp substances across the country.
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention.
The Czech Republic is continuing to make progress on an ambitious overhaul of its drug policies, with sweeping reforms aimed at creating a regulated market for low-risk psychoactive substances and addressing long-standing issues in medical cannabis access.
Efforts to regulate intoxicating hemp substances in Illinois were shot down this week in what the state’s Governor JB Pritzker called a missed opportunity.
The Czech Republic’s lower house has passed a proposal seeking to regulate ‘psychomodulating’ substances, which is likely to include synthetic cannabinoids such as HHC.
Authorities have recently raided a leading CBD contract manufacturing company in Iasi, Romania in what the company has described as an ‘absurd and disproportionate measure’.
STATES across Europe are continuing to ban hexahydrocannabinol (HHC) at pace as politicians warn that the substance is ‘currently flooding our continent’.
